{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:36:11Z","timestamp":1790757371643,"version":"4.1.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,30]]},"abstract":"Abstract<\/jats:title>\n \n STUDY QUESTION<\/jats:title>\n Is female infertility among women seeking medically assisted reproduction (MAR) associated with prevalent as well as incident multiple sclerosis (MS)?<\/jats:p>\n <\/jats:sec>\n \n SUMMARY ANSWER<\/jats:title>\n Women with a record of female infertility did not have an increased risk of developing MS compared with apparent fertile women; however, the prevalence of MS was slightly higher among women undergoing MAR compared with women who had a child without MAR, but this was not related to origin of infertility (i.e. male versus female factor infertility).<\/jats:p>\n <\/jats:sec>\n \n WHAT IS KNOWN ALREADY<\/jats:title>\n Women with MS have fewer children compared with women without MS. Persons with MS more often have other coexisting autoimmune disorders including hypothyroidism compared with the general population. Thyroid dysfunction is associated with ovarian cause of infertility, miscarriage and ovarian failure. Conversely, women with endometriosis, that is highly associated with infertility, also more often have other coexisting autoimmune diseases including MS and hypothyroidism compared with the general population. However, whether the low fertility rate among women with MS is due to a genetically predisposition to other autoimmune and endocrine disorders that leads to reduced fertility, or an active choice of the woman, disease-related pathology or treatment-specific effect on endocrine and\/or ovarian function, is not completely understood.<\/jats:p>\n <\/jats:sec>\n \n STUDY DESIGN, SIZE, DURATION<\/jats:title>\n A register-based cohort study of a total of 310 357 women from 1996 to 2018. A cross-sectional design was used for analysing prevalence of MS, whereas a cohort design with up to 24 years of follow-up was used for analysing incidence of MS.<\/jats:p>\n <\/jats:sec>\n \n PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n Three cohorts were included in the study (i) 55 404 women with a female infertility diagnosis registered in the Danish IVF register; (ii) 25 096 women with only male factor infertility recorded in the IVF register and thus no female infertility diagnosis and (iii) 229 857 age- and calendar-matched women with a record of first child birth in the Danish Medical Birth Register (DMBR) and no record ever in the IVF register. The prevalence and incidence of MS in the female infertility cohort were compared with the two control cohorts of apparent fertile women using log-binomial regression and Cox proportional hazard regression, respectively.<\/jats:p>\n <\/jats:sec>\n \n MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n The crude prevalence of having MS per 1000 persons was 3.2 for women who had undergone MAR treatment regardless of origin of infertility (i.e. male versus female factor infertility) and 2.3 for fertile DMBR controls. The age, calendar and educational level adjusted prevalence ratio of having a diagnosis of MS at the first MAR treatment was 1.27 (95% CI 1.07\u20131.52) for infertile women compared with fertile DMBR controls, and 1.00 (95% CI 0.77\u20131.31) for comparison to women with a male partner with infertility who had also undergone MAR treatment. We found no association between incident MS and female infertility compared with either of the control groups of fertile women.<\/jats:p>\n <\/jats:sec>\n \n LIMITATIONS, REASON FOR CAUTION<\/jats:title>\n The cohort of infertile women is highly selected on the basis of their choice of having fertility treatment and thus does not include women with unestablished infertility or women who, for some reason, have chosen not to have MAR treatment. Additionally, due to the nature of the observational study design, we cannot exclude the possibility of unmeasured and\/or residual confounding.<\/jats:p>\n <\/jats:sec>\n \n WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n Our results suggest that women with MS may undergo MAR treatment more often than women without MS due to more awareness about the possibility of MAR treatments, sexual dysfunction related to MS disease, but also need for timing of the pregnancy to avoid an unnecessary long time period without disease modifying therapy\u2014especially of high efficacy\u2014and hence a wish to conceive quickly. These findings are important for clinicians dealing with women with MS of childbearing age.<\/jats:p>\n <\/jats:sec>\n \n STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n The authors received no financial support for the study. T.I.K. has served on a scientific advisory board for Novartis and has received support for congress participation from Biogen. M.M. has served on scientific advisory boards for Biogen, Sanofi, Roche, Novartis, Merck, Abbvie and Alexion. She has received honoraria for lecturing from Biogen, Merck, Novartis, Sanofi and Genzyme and has received research support and support for congress participation from Biogen, Genzyme, Roche, Merck and Novartis. The remaining authors declare no conflict of interest.<\/jats:p>\n <\/jats:sec>\n \n TRIAL REGISTRATION NUMBER<\/jats:title>\n N\/A.<\/jats:p>\n <\/jats:sec>","DOI":"10.1093\/humrep\/deac041","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T20:11:41Z","timestamp":1645819901000},"page":"1324-1333","source":"Crossref","is-referenced-by-count":12,"title":["Women with female infertility seeking medically assisted reproduction are not at increased risk of developing multiple sclerosis"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3729-4420","authenticated-orcid":false,"given":"T I","family":"Kopp","sequence":"first","affiliation":[{"name":"The Danish Multiple Sclerosis Registry, Department of Neurology, Rigshospitalet, Copenhagen University Hospital , Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8340-104X","authenticated-orcid":false,"given":"A","family":"Pinborg","sequence":"additional","affiliation":[{"name":"The Fertility Clinic, Rigshospitalet, Copenhagen University Hospital , Copenhagen \u00d8, Denmark"},{"name":"Institute of Clinical Medicine, University of Copenhagen , Copenhagen \u00d8, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C H","family":"Glazer","sequence":"additional","affiliation":[{"name":"Department of Urology, Rigshospitalet, Copenhagen University Hospital , Copenhagen \u00d8, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0972-5222","authenticated-orcid":false,"given":"M","family":"Magyari","sequence":"additional","affiliation":[{"name":"The Danish Multiple Sclerosis Registry, Department of Neurology, Rigshospitalet, Copenhagen University Hospital , Glostrup, Denmark"},{"name":"Department of Neurology, Danish Multiple Sclerosis Center, Rigshospitalet, Copenhagen University Hospital , Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"2022060105570918100_deac041-B1","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1212\/CPJ.0000000000001035","article-title":"Pregnancy-related and perinatal outcomes in women with multiple sclerosis","volume":"11","author":"Andersen","year":"2021","journal-title":"Neurol Clin Pract"},{"key":"2022060105570918100_deac041-B2","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1080\/14656566.2020.1774554","article-title":"Pharmacotherapeutic considerations in women with multiple sclerosis","volume":"21","author":"Andersen","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"2022060105570918100_deac041-B3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10654-018-0356-1","article-title":"The Danish Medical Birth Register","volume":"33","author":"Bliddal","year":"2018","journal-title":"Eur J Epidemiol"},{"key":"2022060105570918100_deac041-B4","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1177\/1352458519865118","article-title":"Effect of assisted reproductive technology on multiple sclerosis relapses: Case series and meta-analysis","volume":"26","author":"Bove","year":"2020","journal-title":"Mult Scler J"},{"key":"2022060105570918100_deac041-B5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0404.2009.01314.x","article-title":"Female sexuality in multiple sclerosis: the multidimensional nature of the problem and the intervention","volume":"121","author":"Bronner","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"2022060105570918100_deac041-B6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10072-006-0676-x","article-title":"Fertility in patients with multiple sclerosis: current knowledge and future perspectives","volume":"27","author":"Cavalla","year":"2006","journal-title":"Neurol Sci"},{"key":"2022060105570918100_deac041-B7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jns.2012.08.019","article-title":"Sexual dysfunction in multiple sclerosis: gender differences","volume":"324","author":"\u00c7elik","year":"2013","journal-title":"J Neurol Sci"},{"key":"2022060105570918100_deac041-B8","first-page":"288","article-title":"Assessment of ovarian stromal artery Doppler characteristics and serum hormone levels in patients with Beh\u00e7et disease","volume":"16","author":"\u00c7il","year":"2010","journal-title":"Diagn Interv Radiol"},{"key":"2022060105570918100_deac041-B9","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/ana.23745","article-title":"Increase in multiple sclerosis activity after assisted reproduction technology","volume":"72","author":"Correale","year":"2012","journal-title":"Ann Neurol"},{"key":"2022060105570918100_deac041-B10","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1177\/1352458512471880","article-title":"Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis","volume":"19","author":"Cree","year":"2013","journal-title":"Mult Scler"},{"key":"2022060105570918100_deac041-B11","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S1473-3099(16)30092-5","article-title":"Risk of reproductive complications following chlamydia testing: a population-based retrospective cohort study in Denmark","volume":"16","author":"Davies","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2022060105570918100_deac041-B12","first-page":"837","article-title":"Pregnancy in the setting of multiple sclerosis","volume":"22","author":"Fabian","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"key":"2022060105570918100_deac041-B13","first-page":"248","article-title":"High incidence of hyperandrogenism-related clinical signs in patients with multiple sclerosis","volume":"22","author":"Falaschi","year":"2001","journal-title":"Neuroendocrinol Lett"},{"key":"2022060105570918100_deac041-B14","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/humrep\/dex097","article-title":"Risk of diabetes according to male factor infertility: a register-based cohort study","volume":"32","author":"Glazer","year":"2017","journal-title":"Hum Reprod"},{"key":"2022060105570918100_deac041-B15","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1177\/1352458517734069","article-title":"Male factor infertility and risk of multiple sclerosis: a register-based cohort study","volume":"24","author":"Glazer","year":"2018","journal-title":"Mult Scler"},{"key":"2022060105570918100_deac041-B16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2796.1989.tb01387.x","article-title":"Serum sex hormone and gonadotropin concentrations in premenopausal women with multiple sclerosis","volume":"226","author":"Grinsted","year":"1989","journal-title":"J Intern Med"},{"key":"2022060105570918100_deac041-B17","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s00415-008-0607-2","article-title":"Increased MS relapse rate during assisted reproduction technique","volume":"255","author":"Hellwig","year":"2008","journal-title":"J Neurol"},{"key":"2022060105570918100_deac041-B18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000177937","article-title":"Increase in relapse rate during assisted reproduction technique in patients with multiple sclerosis","volume":"61","author":"Hellwig","year":"2009","journal-title":"Eur Neurol"},{"key":"2022060105570918100_deac041-B19","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1177\/1352458510372629","article-title":"Pregnancy outcome in women with multiple sclerosis: results from a prospective nationwide study in Finland","volume":"16","author":"Jalkanen","year":"2010","journal-title":"Mult Scler"},{"key":"2022060105570918100_deac041-B20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10654-021-00742-8","article-title":"The Danish National Register of assisted reproductive technology: content and research potentials","volume":"36","author":"J\u00f8lving","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"2022060105570918100_deac041-B21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00415-016-8041-3","article-title":"Two cases of multiple sclerosis manifesting after in vitro fertilization procedures","volume":"263","author":"Ladwig","year":"2016","journal-title":"J Neurol"},{"key":"2022060105570918100_deac041-B22","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1001\/jama.279.21.1703","article-title":"Socioeconomic factors, health behaviors, and mortality: results from a nationally representative prospective study of US adults","volume":"279","author":"Lantz","year":"1998","journal-title":"J Am Med Assoc"},{"key":"2022060105570918100_deac041-B23","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1212\/01.wnl.0000208521.10685.a6","article-title":"Increase in multiple sclerosis relapse rate following in vitro fertilization","volume":"66","author":"Laplaud","year":"2006","journal-title":"Neurology"},{"key":"2022060105570918100_deac041-B24","doi-asserted-by":"crossref","first-page":"e01921","DOI":"10.1002\/brb3.1921","article-title":"The Danish Multiple Sclerosis Registry","volume":"11","author":"Magyari","year":"2021","journal-title":"Brain Behav"},{"key":"2022060105570918100_deac041-B25","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1177\/1352458514521515","article-title":"Gender and autoimmune comorbidity in multiple sclerosis","volume":"20","author":"Magyari","year":"2014","journal-title":"Mult Scler"},{"key":"2022060105570918100_deac041-B26","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3389\/fneur.2020.00851","article-title":"Comorbidity in multiple sclerosis","volume":"11","author":"Magyari","year":"2020","journal-title":"Front Neurol"},{"key":"2022060105570918100_deac041-B27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1352458514549406","article-title":"Female infertility and multiple sclerosis: Is this an issue?","volume":"21","author":"McCombe","year":"2015","journal-title":"Mult Scler"},{"key":"2022060105570918100_deac041-B28","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/jnnp-2012-302235","article-title":"Increased risk of multiple sclerosis relapse after in vitro fertilisation","volume":"83","author":"Michel","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2022060105570918100_deac041-B29","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1177\/1352458519851245","article-title":"Reproductive history of the Danish multiple sclerosis population: a register-based study","volume":"26","author":"Moberg","year":"2020","journal-title":"Mult Scler"},{"key":"2022060105570918100_deac041-B30","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00415-003-1053-9","article-title":"Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis","volume":"250","author":"Niederwieser","year":"2003","journal-title":"J Neurol"},{"key":"2022060105570918100_deac041-B31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.beem.2004.03.004","article-title":"Female infertility and the thyroid","volume":"18","author":"Poppe","year":"2004","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2022060105570918100_deac041-B32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrendo.2013.212","article-title":"Endocrine autoimmune diseases and female infertility","volume":"10","author":"Sen","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"2022060105570918100_deac041-B33","doi-asserted-by":"crossref","first-page":"697974","DOI":"10.3389\/fneur.2021.697974","article-title":"Influence of pregnancy in multiple sclerosis and impact of disease-modifying therapies","volume":"12","author":"Simone","year":"2021","journal-title":"Front Neurol"},{"key":"2022060105570918100_deac041-B34","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1093\/humrep\/17.10.2715","article-title":"High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis","volume":"17","author":"Sinaii","year":"2002","journal-title":"Hum Reprod"},{"key":"2022060105570918100_deac041-B35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/1352458514540843","article-title":"Serum anti-M\u00fcllerian hormone levels in reproductive-age women with relapsing-remitting multiple sclerosis","volume":"21","author":"Th\u00f6ne","year":"2015","journal-title":"Mult Scler J"},{"key":"2022060105570918100_deac041-B36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jns.2014.11.016","article-title":"Tumefactive demyelination following in vitro fertilization (IVF)","volume":"348","author":"Vaknin-Dembinsky","year":"2015","journal-title":"J Neurol Sci"},{"key":"2022060105570918100_deac041-B37","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015069","article-title":"Phenome-wide analysis of short-and long-run disease incidence following recurrent pregnancy loss using data from a 39-year period","volume":"9","author":"Westergaard","year":"2020","journal-title":"J Am Heart Assoc"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/6\/1324\/43889771\/deac041.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/6\/1324\/43889771\/deac041.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T05:57:51Z","timestamp":1654063071000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/37\/6\/1324\/6546191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":37,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,3,10]]},"published-print":{"date-parts":[[2022,5,30]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deac041","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6,1]]},"published":{"date-parts":[[2022,3,10]]}}}